| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/01/2011 | US7897563 Use of oligomers and polymers for drug solubilization, stabilization, and delivery |
| 03/01/2011 | US7897179 Beads coated with drugs; forming supersaturated solution; controlling temperature |
| 03/01/2011 | US7897178 Water-swellable clay mineral laminated powder, dye/water-swellable clay mineral complex and composition comprising the same |
| 03/01/2011 | US7897177 Particulate fibre composition |
| 03/01/2011 | US7897176 Hybrid composite dispersion; polycarbonateether block copolymer in aqueous solution |
| 03/01/2011 | US7897175 Cholesteryl ester transfer protein (CETP) such as torcetrapib; 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase); two drugs are separate from each other; improved chemical stability of the HMG-CoA reductase inhibitor |
| 03/01/2011 | US7897174 Formulation comprising bioactive agents and method of using same |
| 03/01/2011 | US7897173 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 03/01/2011 | US7897172 Tablets exhibiting reduced drug release variability |
| 03/01/2011 | US7897166 Biodegradable ceramic fibres from silica sols |
| 03/01/2011 | US7897160 Conjugated fatty acid based emulsion and methods for preparing and using same |
| 03/01/2011 | US7897154 Culture filtrate concentrate from Basidiomycetes; Parkinson's disease; diabetes |
| 03/01/2011 | US7897080 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 03/01/2011 | US7896868 Method and system for control of osmotic pump device |
| 03/01/2011 | US7896867 Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method |
| 03/01/2011 | US7896866 System and method for making an implantable pump thinner |
| 03/01/2011 | US7896865 Two-compartment reduced volume infusion pump |
| 03/01/2011 | US7896018 Dosage control apparatus |
| 03/01/2011 | CA2658585C Transmucosal delivery devices with enhanced uptake |
| 03/01/2011 | CA2542657C Muscarinic acetylcholine receptor antagonists |
| 03/01/2011 | CA2527088C Stabilized pharmaceutical product |
| 03/01/2011 | CA2511974C Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 03/01/2011 | CA2423335C Spray drying process and compositions of fenofibrate |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 03/01/2011 | CA2326322C Free-form nanofabrication using multi-photon excitation |
| 02/25/2011 | CA2676583A1 Substances for reducing occurrence of major cardiac events in humans |
| 02/24/2011 | WO2011022737A2 Tablet manufacture |
| 02/24/2011 | WO2011022652A1 Topical gels |
| 02/24/2011 | WO2011022532A2 Methods for concomitant administration of colchicine and a second active agent |
| 02/24/2011 | WO2011022491A1 Cysteine for physiological injection |
| 02/24/2011 | WO2011022467A2 Controlled-release formulations of anabaseine compounds and uses thereof |
| 02/24/2011 | WO2011022460A1 Novel cationic lipids with various head groups for oligonucleotide delivery |
| 02/24/2011 | WO2011022433A1 Vaporized lobelia product and method of use |
| 02/24/2011 | WO2011022396A1 Lipid construct for delivery of insulin to a mammal |
| 02/24/2011 | WO2011022389A1 Compositions and methods for wound healing |
| 02/24/2011 | WO2011022371A2 Gel product |
| 02/24/2011 | WO2011022318A1 Chocolate delivery system for pharmaceuticals and nutraceuticals |
| 02/24/2011 | WO2011022291A2 Photoregulated reversible hydrogels for delivery and releasing of drugs and other therapeutical reagents |
| 02/24/2011 | WO2011022199A2 Multi-layer transdermal patch |
| 02/24/2011 | WO2011022074A1 Riboflavin based aerosol and use as placebo in trials |
| 02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | WO2011021594A1 Sustained drug delivery system |
| 02/24/2011 | WO2011020866A2 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | WO2011020829A1 Water-soluble polysaccharide ethers and the use thereof |
| 02/24/2011 | WO2011020610A1 Drug delivery systems (wafer) for pediatric use |
| 02/24/2011 | WO2011020527A1 Process for compressing isomalt |
| 02/24/2011 | WO2011020311A1 Use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer |
| 02/24/2011 | WO2010148013A3 Lipid formulated dsrna targeting the pcsk9 gene |
| 02/24/2011 | WO2010144464A3 Solid dispersions containing an apoptosis-promoting agent |
| 02/24/2011 | WO2010139746A3 Spray-dried dye compositions, process for the production and use thereof |
| 02/24/2011 | WO2010137855A9 Multi-layer tablet comprising effervescent layer |
| 02/24/2011 | WO2010135053A3 Dual and single layer dosage forms |
| 02/24/2011 | WO2010129788A3 Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders |
| 02/24/2011 | WO2010115172A3 Antigenic peptide of hsv-2 and methods for using same |
| 02/24/2011 | WO2010114710A3 An artificial micro-gland |
| 02/24/2011 | WO2010112489A3 Method for producing preparations of substances poorly soluble in water |
| 02/24/2011 | WO2010111264A3 Rasagiline formulations |
| 02/24/2011 | WO2010104575A3 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 02/24/2011 | WO2010102041A3 Nutritional composition and method for control of diabetes by lowering of the blood sugar level |
| 02/24/2011 | WO2010066437A3 Aqueous composition containing dexpanthenol and sodium chloride |
| 02/24/2011 | WO2010043772A3 Method of protecting cells |
| 02/24/2011 | WO2010034688A3 Use of polyether-based and vinyl monomer-based copolymers as binders for dosing forms comprising solid active ingredients |
| 02/24/2011 | WO2009099641A3 Stabilized protein compositions |
| 02/24/2011 | WO2008020318A3 Non-viral compositions and methods for transfecting gut cells in vivo |
| 02/24/2011 | WO2008017962A3 Microcapsules with improved shells |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046546 Methods for treating headaches |
| 02/24/2011 | US20110046193 Deferacirox dispersible tablets |
| 02/24/2011 | US20110046181 Short duration depot formulations |
| 02/24/2011 | US20110046100 Texaphyrin solutions and pharmaceutical formulations |
| 02/24/2011 | US20110046099 Steroid hormone products and methods for preparing them |
| 02/24/2011 | US20110046095 Steroid hormone products and methods for preparing them |
| 02/24/2011 | US20110045983 Gel composition |
| 02/24/2011 | US20110045097 Solid pharmaceutical composition comprising irbesartan |
| 02/24/2011 | US20110045096 Solubilized delivery system for topical anesthetics |
| 02/24/2011 | US20110045095 Polymer-phospholipid shelled microbubbles |
| 02/24/2011 | US20110045094 Encapsulated quantum dot |
| 02/24/2011 | US20110045093 Pharmaceutical composition and process comprising vegetable proteolytic enzymes in supramolecular nanoparticles, for the treatment of peyronie's disease, connective tissue diseases and use |
| 02/24/2011 | US20110045092 Casein particles encapsulating therapeutically active agents and uses thereof |
| 02/24/2011 | US20110045091 Anti-angiogenesis, anticancer proliferation properties of lymphocytic-derived microparticles |
| 02/24/2011 | US20110045090 Formulations of flibanserin |
| 02/24/2011 | US20110045089 Vitamin k3 derivative / nsa formulation |
| 02/24/2011 | US20110045088 Intranasal granisetron and nasal applicator |
| 02/24/2011 | US20110045087 Porous biocompatible polymer material and methods |
| 02/24/2011 | US20110045086 Steroid Nebuliser Formulation |
| 02/24/2011 | US20110045085 Process for obtaining powder compositions of orlistat |
| 02/24/2011 | US20110045084 Light-curable bone growth material for treating dental bone defects |
| 02/24/2011 | US20110045083 Use larch wood for treating inflammation |
| 02/24/2011 | US20110045082 Agglomerates by crystallisation |
| 02/24/2011 | US20110045081 Magnetic, paramagnetic and/or superparamagnetic nanoparticles |
| 02/24/2011 | US20110045080 Single-Walled Carbon Nanotube/Bioactive Substance Complexes and Methods Related Thereto |
| 02/24/2011 | US20110045079 Dry powders of cellular material |
| 02/24/2011 | US20110045077 Encapsulated pancreatic islet cell products and methods of use thereof |
| 02/24/2011 | US20110045076 Linear order release polymer |
| 02/24/2011 | US20110045075 Tissue coating for preventing undesired tissue-to-tissue adhesions |
| 02/24/2011 | US20110045074 Matrix type sustained-release preparation containing basic drug or salt thereof and, method for manufacturing the same |
| 02/24/2011 | US20110045073 Methods and compositions of sphingolipid for preventing and treating microbial infections |
| 02/24/2011 | US20110045072 Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix |
| 02/24/2011 | US20110045071 Generation of a novel type of anti-inflammatory macrophages for clinical use |
| 02/24/2011 | US20110045070 Combination therapy |